An overview of the pathogenesis of cystic fibrosis lung disease

Advanced Drug Delivery Reviews

Volumn 54, Issue 11, 2002, Pages 1359-1371

  Boucher, R C ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Airway surface liquid; Anaerobic; Cystic fibrosis transmembrane conductance regulator; Ion transport

Indexed keywords

BIOLOGICAL MEMBRANES; PHYSIOLOGY; PULMONARY DISEASES; TRANSPORT PROPERTIES;

PATHOGENESIS;

PATHOLOGY;

CHLORIDE ION; MUCIN; SODIUM ION; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ABSORPTION; AIRWAY; AIRWAY SURFACE LIQUID; APICAL MEMBRANE; BACTERIAL IMMUNITY; BACTERIAL INFECTION; BRONCHUS MUCUS; CILIARY MOTILITY; CLEARANCE; CYSTIC FIBROSIS; EPITHELIUM CELL; HUMAN; LIQUID; LUNG VENTILATION; MICROSCOPY; MUCUS; MUCUS CLEARANCE; MUCUS PLAQUE; MUCUS PLUG; MUCUS SECRETION; PATHOGENESIS; PATHOPHYSIOLOGY; PERICILIARY LIQUID LAYER; PRIORITY JOURNAL; PROTEIN SECRETION; RESPIRATORY AIRFLOW; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT INFECTION; REVIEW; SECRETION; TRACHEA MUCUS;

EID: 0037027912     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(02)00144-8     Document Type: Editorial

References (69)

1. Cystic fibrosis gene analysis consortium, 2000. http://www.genet.sickkids.on.ca/cftr/.
2. Bear C.E., Li C., Kartner N., Bridges R.J., Jensen T.J., Ramjeesingh M., Riordan J.R. Purification and functional reconstitution of the cystic fibrosis transmembrane conductance regulator (CFTR). Cell. 68:1992;809-818.
3. Berger M. Lung inflammation early in cystic fibrosis. Bugs are indicted, but the defense is guilty. Am. J. Respir. Crit. Care Med. 165:2002;857-858.
4. Boucher R.C. Human airway ion transport (Part 1). Am. J. Respir. Crit. Care Med. 150:1994;271-281.
5. Boucher R.C. Human airway ion transport (Part 2). Am. J. Respir. Crit. Care Med. 150:1994;581-593.
6. Boucher R.C. Molecular insights into the physiology of the 'thin film' of airway surface liquid. J. Physiol. (Lond.). 516:1999;631-638.
7. + transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest. 78:1986;1245-1252.
8. + transport in normal and CF human bronchial epithelial cells is inhibited by BAY 39-9437. Am. J. Physiol. 281:2001;L16-L23.
9. Bronsveld I., Mekus F., Bijman J., Ballmann M., de Jonge H.R., Laabs U., Halley D.J., Ellemunter H., Mastella G., Thomas S., Veeze H.J., Tummler B. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J. Clin. Invest. 108:2001;1705-1715.
10. - analysis with solid-state electrodes. J. Gen. Physiol. 119:2002;3-14.
11. Cheng S.H., Gregory R.J., Marshall J., Paul S., Souza D.W., White G.A., O'Riordan C., Smith A.E. Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell. 63:1990;827-834.
12. Chinet T.C., Fullton J.M., Yankaskas J.R., Boucher R.C., Stutts M.J. Sodium-permeable channels in the apical membrane of human nasal epithelial cells. Am. J. Physiol. 265:1993;C1050-C1060.
13. Chinet T.C., Fullton J.M., Yankaskas J.R., Boucher R.C., Stutts M.J. Mechanism of sodium hyperabsorption in cultured cystic fibrosis nasal epithelium: a patch clamp study. Am. J. Physiol. 266:1994;C1061-C1068.
14. Cole A.M., Dewan P., Ganz T. Innate antimicrobial activity of nasal secretions. Infect. Immun. 67:1999;3267-3275.
15. Cutting G.R. Genotype defect: Its effect on cellular function and phenotypic expression. Semin. Respir. Crit. Care Med. 15:1994;356-363.
16. Dakin C.J., Numa A.H., Wang H., Morton J.R., Vertzyas C.C., Henry R.L. Inflammation, infection, and pulmonary function in infants and young children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165:2002;904-910.
17. Donaldson S.H., Hirsh A., Li D.C., Holloway G., Chao J., Boucher R.C., Gabriel S.E. Regulation of the epithelial sodium channel by serine proteases in human airways. J. Biol. Chem. 277:2002;8338-8345.
18. Drumm M.L., Wilkinson D.J., Smith L.S., Worrell R.T., Strong T.V., Frizzell R.A., Dawson D.C., Collins F.S. Chloride conductance expressed by delta F508 and other mutant CFTRs in Xenopus oocytes. Science. 254:1991;1797-1799.
19. Goldman M.J., Anderson G.M., Stolzenberg E.D., Kari U.P., Zasloff M., Wilson J.M. Human beta-defensin-1 is a salt-sensitive antibiotic that is inactivated in cystic fibrosis. Cell. 88:1997;553-560.
20. Grubb B.R., Chadburn J.L., Boucher R.C. In vivo microdialysis for the determination of ariway surface liquid ion composition. Am. J. Physiol. 282:2002;C1423-C1431.
21. Guggino W.B. Cystic fibrosis and the salt controversy. Cell. 96:1999;607-610.
22. Hull J., Skinner W., Robertson C., Phelan P. Elemental content of airway surface liquid from infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 157:1998;10-14.
23. Imundo L., Barasch J., Prince A., Al-Awqati Q. Cystic fibrosis epithelial cells have a receptor for pathogenic bacteria on their apical surface. Proc. Natl. Acad. Sci. USA. 92:1995;3019-3023.
24. Jayaraman S., Song Y., Vetrivel L., Shankar L., Verkman A.S. Noninvasive in vivo fluorescence measurement of airway-surface liquid depth, salt concentration, and pH. J. Clin. Invest. 107:2001;317-324.
25. Jiang C., Finkbeiner W.E., Widdicombe J.H., McCray P.B. Jr., Miller S.S. Altered fluid transport across airway epithelium in cystic fibrosis. Science. 262:1993;424-427.
26. Johnson L.G., Boyles S.E., Wilson J., Boucher R.C. Normalization of raised sodium absorption and raised calcium-mediated chloride secretion by adenovirus-mediated expression of cystic fibrosis transmembrane conductance regulator in primary human cystic fibrosis airway epithelial cells. J. Clin. Invest. 95:1995;1377-1382.
27. Joris L., Dab I., Quinton P.M. Elemental composition of human airway surface liquid in healthy and diseased airways. Am. Rev. Respir. Dis. 148:1993;1633-1637.
28. Kalin N., Claabeta A., Sommer M., Puchelle E., Tummler B. DeltaF508 CFTR protein expression in tissues from patients with cystic fibrosis. J. Clin. Invest. 103:1999;1379-1389.
29. Kerem E., Bistritzer T., Hanukoglu A., Hofmann T., Zhou Z., Bennett W., MacLaughlin E., Barker P., Nash M., Quittell L., Boucher R., Knowles M.R. Pulmonary epithelial sodium channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N. Engl. J. Med. 341:1999;156-162.
30. 508 ). N. Engl. J. Med. 323:1990;1517-1522.
31. Khan T.Z., Wagener J.S., Bost T., Martinez J., Accurso F.J., Riches D.W.H. Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151:1995;1075-1082.
32. Kilburn K.H. A hypothesis for pulmonary clearance and its implications. Am. Rev. Respir. Dis. 98:1968;449-463.
33. Knowles M., Gatzy J., Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N. Engl. J. Med. 305:1981;1489-1495.
34. Knowles M.R., Boucher R.C. Mucus clearance as a primary innate defense mechanism for mammalian airways ('Perspective'). J. Clin. Invest. 109:2002;571-577.
35. Knowles M.R., Robinson J.M., Wood R.E., Pue C.A., Mentz W.M., Wager G.C., Gatzy J.T., Boucher R.C. Ion composition of airway surface liquid of patients with cystic fibrosis as compared to normal and disease-control subjects. J. Clin. Invest. 100:1997;2588-2595.
36. Knowles M.R., Stutts M.J., Spock A., Fischer N., Gatzy J.T., Boucher R.C. Abnormal ion permeation through cystic fibrosis respiratory epithelium. Science. 221:1983;1067-1070.
37. Kreda S.M., Gynn M.C., Fenstermacher D.A., Boucher R.C., Gabriel S.E. Expression and localization of epithelial aquaporins in the adult human lung. Am. J. Respir. Cell Mol. Biol. 24:2001;224-234.
38. Lamblin G., Degroote S., Perini J.M., Delmotte P., Scharfman A., Davril M., Lo-Guidice J.M., Houdret N., Klein A., Roussel P. Human airway mucin glycosylation: a combinatory of carbohydrate determinants which vary in cystic fibrosis. BioLeXis. 1:2000;47.
39. Loo M.A., Jensen T.J., Cui L., Hou Y., Chang X.B., Riordan J.R. Perturbation of Hsp90 interaction with nascent CFTR prevents its maturation and accelerates its degradation by the proteasome. EMBO J. 17:1998;6879-6887.
40. Mahadeva R., Sharples L., Ross-Russell R.I., Webb A.K., Bilton D., Lomas D.A. Association of alpha(1)-antichymotrypsin deficiency with milder lung disease in patients with cystic fibrosis. Thorax. 56:2001;53-58.
41. Matsui H., Grubb B.R., Tarran R., Randell S.H., Gatzy J.T., Davis C.W., Boucher R.C. Evidence for periciliary liquid layer depletion, not abnormal ion composition, in the pathogenesis of cystic fibrosis airways disease. Cell. 95:1998;1005-1015.
42. Matsui H., Randell S.H., Peretti S.W., Davis C.W., Boucher R.C. Coordinated clearance of periciliary liquid and mucus from airway surfaces. J. Clin. Invest. 102:1998;1125-1131.
43. Muhlebach M.S., Noah T.L. Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165:2002;911-915.
44. Pier G.B., Grout M., Zaidi T.S., Olsen J.C., Johnson L.G., Yankaskas J.R., Goldberg J.B. Role of mutant CFTR in hypersusceptibility of cystic fibrosis patients to lung infections. Science. 271:1996;64-67.
45. Proctor D.F., Lundqvist G. Clearance of inhaled particles from the human nose. Arch. Intern. Med. 131:1973;132-139.
46. Quinton P.M. Chloride impermeability in cystic fibrosis. Nature. 301:1983;421-422.
47. Regnis J.A., Zeman K.L., Noone P.G., Knowles M.R., Bennett W.D. Prolonged airway retention of insoluble particles in cystic fibrosis versus primary ciliary dyskinesia. Exp. Lung Res. 26:2000;149-162.
48. Ribeiro C.P., Paradiso A.M., Boucher R.C. Upregulation of the apical endoplasmic reticulum (ER) network in cystic fibrosis (CF) human airway epithelia [Abstract]. Pediatr. Pulmonol. Suppl. 22:2001;235-236.
49. Rich D.P., Anderson M.P., Gregory R.J., Cheng S.H., Paul S., Jefferson D.M., McCann J.D., Klinger K.W., Smith A.E., Welsh M.J. Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature. 347:1990;358-363.
50. Smith J.J., Travis S.M., Greenberg E.P., Welsh M.J. Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid. Cell. 85:1996;229-236.
51. Stutts M.J., Canessa C.M., Olsen J.C., Hamrick M., Cohn J.A., Rossier B.C., Boucher R.C. CFTR as a cAMP-dependent regulator of sodium channels. Science. 269:1995;847-850.
52. Stutts M.J., Knowles M.R., Gatzy J.T., Boucher R.C. Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium. Pediatr. Res. 20:1986;1316-1320.
53. Tarran R., Grubb B.R., Gatzy J.T., Davis C.W., Boucher R.C. The relative roles of passive surface forces and active ion transport in the modulation of airway surface liquid volume and composition. J. Gen. Physiol. 118:2001;223-236.
54. Tarran R., Grubb B.R., Parsons D., Picher M., Hirsch A.J., Davis C.W., Boucher R.C. The CF salt controversy: In vivo observations and therapeutic approaches. Mol. Cell. 8:2001;149-158.
55. Tsui L.-C. The spectrum of cystic fibrosis mutations. Trends Genet. 8:1992;392-398.
56. Tuemmler B., Kiewitz C. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections. Mol. Med. Today. 5:1999;351-358.
57. Vallet V., Chraibi A., Gaeggeler H.P., Horisberger J.D., Rossier B.C. An epithelial serine protease activates the amiloride-sensitive sodium channel. Nature. 389:1997;607-610.
58. Wanner A., Salathe M., O'Riordan T.G. Mucociliary clearance in the airways. Am. J. Respir. Crit. Care Med. 154:1996;1868-1902.
59. Ward C.L., Omura S., Kopito R.R. Degradation of CFTR by the ubiquitin-proteasome pathway. Cell. 83:1995;121-127.
60. Welsh M.J., Smith A.E. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell. 73:1993;1251-1254.
61. Welsh M.J., Tsui L-C. Boat T.F., Beaudet A.L. Cystic fibrosis. Scriver C.R., Beaudet A.L., Sly W.S., Valle D., Stanbury J.B., Wyngaarden J.B., Fredrickson D.S. The Metabolic and Molecular Bases of Inherited Disease. Vol. 7:1995;3799-3876 McGraw-Hill, New York.
62. 2+ ionophores in cystic fibrosis airway epithelia. Am. J. Physiol. 256:1989;C226-C233.
63. Willumsen N.J., Boucher R.C. Sodium transport and intracellular sodium activity in cultured human nasal epithelium. Am. J. Physiol. 261:1991;C319-C331.
64. Willumsen N.J., Boucher R.C. Transcellular sodium transport in cultured cystic fibrosis human nasal epithelium. Am. J. Physiol. 261:1991;C332-C341.
65. Wine J.J. The genesis of cystic fibrosis lung disease. J. Clin. Invest. 103:1999;309-312.
66. Worlitzsch D., Tarran R., Ulrich M., Schwab U., Cekici A., Meyer K.C., Birrer P., Bellon G., Berger J., Weiss T., Botzenhart K., Yankaskas J.R., Randell S., Boucher R.C., Doering G. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:2002;317-325.
67. Zabner J., Smith J.J., Karp P.H., Widdicombe J.H., Welsh M.J. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol. Cell. 2:1998;397-403.
68. Zielenski J., Corey M., Rozmahel R., Markiewicz D., Aznarez I., Casals T., Larriba S., Mercier B., Cutting G.R., Krebsova A., Macek M. Jr., Langfelder-Schwind E., Marshall B.C., DeCelie-Germana J., Claustres M., Palacio A., Bal J., Nowakowska A., Ferec C., Estivill X., Durie P., Tsui L.C. Detection of a cystic fibrosis modifier locus for meconium ileus on human chromosome 19q13. Nat. Genet. 22:1999;128-129.
69. Zielenski J., Tsui L.C. Cystic fibrosis: genotypic and phenotypic variations. Annu. Rev. Genet. 29:1995;777-807.